These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32131606)

  • 61. Restoring the Microbiome in Critically Ill Patients: Are Probiotics Our True Friends When We Are Seriously Ill?
    Manzanares W; Langlois PL; Wischmeyer PE
    JPEN J Parenter Enteral Nutr; 2017 May; 41(4):530-533. PubMed ID: 28445681
    [No Abstract]   [Full Text] [Related]  

  • 62. Engineering probiotics as living diagnostics and therapeutics for improving human health.
    Zhou Z; Chen X; Sheng H; Shen X; Sun X; Yan Y; Wang J; Yuan Q
    Microb Cell Fact; 2020 Mar; 19(1):56. PubMed ID: 32131831
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.
    Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
    Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
    J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Gut Microbiota in Celiac Disease and probiotics.
    Chibbar R; Dieleman LA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gut Microbiome as Target for Innovative Strategies Against Food Allergy.
    Berni Canani R; Paparo L; Nocerino R; Di Scala C; Della Gatta G; Maddalena Y; Buono A; Bruno C; Voto L; Ercolini D
    Front Immunol; 2019; 10():191. PubMed ID: 30828329
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of gut microbiota in idiopathic nephrotic syndrome in children.
    Kaneko K; Tsuji S; Kimata T
    Med Hypotheses; 2017 Oct; 108():35-37. PubMed ID: 29055396
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet.
    Kong C; Gao R; Yan X; Huang L; Qin H
    Nutrition; 2019 Apr; 60():175-184. PubMed ID: 30611080
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
    Singh D; Khan MA; Siddique HR
    Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The human-microbiome superorganism and its modulation to restore health.
    Salvucci E
    Int J Food Sci Nutr; 2019 Nov; 70(7):781-795. PubMed ID: 30843443
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The gut microbiome.
    Sidhu M; van der Poorten D
    Aust Fam Physician; 2017; 46(4):206-211. PubMed ID: 28376573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of the Gut Microbiota in Stroke Pathogenesis and Potential Therapeutic Implications.
    Yamashiro K; Kurita N; Urabe T; Hattori N
    Ann Nutr Metab; 2021; 77 Suppl 2(Suppl 2):36-44. PubMed ID: 34107468
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gut microbiota: A target for heavy metal toxicity and a probiotic protective strategy.
    Duan H; Yu L; Tian F; Zhai Q; Fan L; Chen W
    Sci Total Environ; 2020 Nov; 742():140429. PubMed ID: 32629250
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.
    Singh R; Zogg H; Wei L; Bartlett A; Ghoshal UC; Rajender S; Ro S
    J Neurogastroenterol Motil; 2021 Jan; 27(1):19-34. PubMed ID: 33166939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gut Microbiota in Cardiovascular Health and Disease.
    Tang WH; Kitai T; Hazen SL
    Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure.
    Chen X; Li HY; Hu XM; Zhang Y; Zhang SY
    Chin Med J (Engl); 2019 Aug; 132(15):1843-1855. PubMed ID: 31306229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.